Evidence map›Paper›PMID 24884705›Full record

ArticleBMC cancer2014

Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study.

Heather Greenlee, Marilyn L Kwan, Isaac J Ergas, Garrett Strizich, Janise M Roh, Allegra T Wilson, Marion Lee, Karen J Sherman, Christine B Ambrosone, Dawn L Hershman and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06137833 (Clinical Study on Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy), which is not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06137833 narecruitingnot on this mapstarted 2023, after this paper: background citation

Clinical Study on Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy

TypeinterventionalSponsorPharmanutra S.p.a.Ran2023 to 2025Enrolled92ConditionsFatigue, Breast CancerArmsAPPOPRTAL®, Placebo
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Do cancer survivors change their diet after cancer diagnosis?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Complementary and alternative medicine use among US cancer survivors.Journal of cancer survivorship : research and practice · 2016
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Heather GreenleeMailman School of Public Health, Columbia University, New York, NY 10032, USA. hg2120@columbia.edu.
Marilyn L Kwan
Isaac J Ergas
Garrett Strizich
Janise M Roh
Allegra T Wilson
Marion Lee
Karen J Sherman
Christine B Ambrosone
Dawn L Hershman
Alfred I Neugut
Lawrence H Kushi
Kaiser Permanente · USColumbia University · USColumbia University Irving Medical Center · USKaiser Permanente Washington Health Research Institute · USRoswell Park Comprehensive Cancer Center · USUniversity of California, San Francisco · US

Funding

True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
Prospective Study of Breast Cancer SurvivorshipR01CA105274 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI KUSHI, LAWRENCE H · 2004 to 2014
$19.9M
Effects of Antioxidant Supplementation during Breast Cancer Adjuvant TherapyK23CA141052 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GREENLEE, HEATHER · 2009 to 2013
$753k
NCI NIH HHS K23CA141052NCI NIH HHS R01 CA105274NCI NIH HHS R01CA105274NIEHS NIH HHS P30 ES009089
6 · The paper itself

Abstract

backgroundVitamin and mineral supplement use after a breast cancer diagnosis is common and controversial. Dosages used and the timing of initiation and/or discontinuation of supplements have not been clearly described.

methodsWe prospectively examined changes in use of 17 vitamin/mineral supplements in the first six months following breast cancer diagnosis among 2,596 members (28% non-white) of Kaiser Permanente Northern California. We used multivariable logistic regression to examine demographic, clinical, and lifestyle predictors of initiation and discontinuation.

resultsMost women used vitamin/mineral supplements before (84%) and after (82%) diagnosis, with average doses far in excess of Institute of Medicine reference intakes. Over half (60.2%) reported initiating a vitamin/mineral following diagnosis, 46.3% discontinuing a vitamin/mineral, 65.6% using a vitamin/mineral continuously, and only 7.2% not using any vitamin/mineral supplement before or after diagnosis. The most commonly initiated supplements were calcium (38.2%), vitamin D (32.01%), vitamin B6 (12.3%) and magnesium (11.31%); the most commonly discontinued supplements were multivitamins (17.14%), vitamin C (15.97%) and vitamin E (45.62%). Higher education, higher intake of fruits/vegetables, and receipt of chemotherapy were associated with initiation (p-values <0.05). Younger age and breast-conserving surgery were associated with discontinuation (p-values <0.05).

conclusionsIn this large cohort of ethnically diverse breast cancer patients, high numbers of women used vitamin/mineral supplements in the 6 months following breast cancer diagnosis, often at high doses and in combination with other supplements. The immediate period after diagnosis is a critical time for clinicians to counsel women on supplement use.

Indexed as

Metabolic Networks and PathwaysAdultAgedAged, 80 and overAge FactorsBreast NeoplasmsCaliforniaDietary SupplementsFemaleHumansLife StyleLogistic ModelsMiddle AgedMineralsProspective StudiesVitaminsMineralsVitamins

Identifiers

PMID24884705
PMCPMC4059470
OpenAlexW1963618078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.